Anti-interleukin-17 antibodies attenuate airway inflammation in tobacco-smoke-exposed mice

Inhalation Toxicology

Volumn 23, Issue 4, 2011, Pages 212-218

  Shen, Ning ^a   Wang, Jing ^a   Zhao, Mingwu ^a   Pei, Fei ^b   He, Bei ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Airway inflammation; antibody; interleukin 17; tobacco smoke exposed

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 6; INTERLEUKIN 8; MUCIN 5AC; TOBACCO SMOKE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; HISTOPATHOLOGY; LUNG ALVEOLUS EPITHELIUM; LUNG FUNCTION TEST; LUNG HOMOGENATE; LUNG LAVAGE; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION;

ANIMALS; ANTIBODIES; BRONCHOALVEOLAR LAVAGE FLUID; INFLAMMATION; INHALATION EXPOSURE; INTERLEUKIN-17; INTERLEUKIN-6; INTERLEUKIN-8; LUNG; LUNG DISEASES; MALE; MICE; MICE, INBRED C57BL; SMOKE; TOBACCO;

MUS; NICOTIANA TABACUM; RATTUS;

EID: 79953672286     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2011.559603     Document Type: Article

References (20)

1. Aggarwal S, Gurney AL. 2002. IL-17: prototype member of an emerging cytokine family. J Leukoc Bio 71:128.
2. Chen Y Tai P, Zhao YH, Ho YS, DeSouza MM, Wu R. 2003. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem 278:17036-17043. (Pubitemid 36799579)
3. Cosio M, Ghezzo H, Hogg JC, Corbin R, Loveland M, Dosman J, Macklem PT. 1978. Te relations between structural changes in small airways and pulmonary-function tests. N Engl J Med 298:1277-1281. (Pubitemid 8361451)
4. Hellings PW, Kasran A, Liu Z, Vandekerckhove P, Wuyts A, Overbergh L, Mathieu C, Ceuppens JL. 2003. Interleukin-17 orchestrates the granulocyte infux into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol 28:42-50. (Pubitemid 36017049)
5. Hymowitz SG, Filvarof EH, Yin JP, Lee J, Cai L, Risser P, Maruoka M, Mao W, Foster J, Kelley RF, Pan G, Gurney AL, de Vos AM, Starovasnik MA. 2001. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J 20:5332-5341. (Pubitemid 32959452)
6. Lee J, Ho WH, Maruoka M, Corpuz RT, Baldwin DT, Foster JS, Goddard AD, Yansura DG, Vandlen RL, Wood WI, Gurney AL. 2001. IL-17E, a novel proinfammatory ligand for the IL-17 receptor homolog IL-17Rh1. J Biol Chem 276:1660-1664. (Pubitemid 32096603)
7. Li H, Chen J, Huang A, Stinson J, Heldens S, Foster J, Dowd P, Gurney AL, Wood WI. 2000. Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc Natl Acad Sci USA 97:773-778. (Pubitemid 30070385)
8. Li YT, He B, Wang YZ. 2009. Exposure to cigarette smoke upregulates AP-1 activity and induces TNF-alpha overexpression in mouse lungs. Inhal Toxicol 21:641-647.
9. Miossec P, Korn T, Kuchroo VK. 2009. Interleukin-17 and type 17 helper T cells. N Engl J Med 361:888-898.
10. Miyamoto M, Prause O, Sjöstrand M, Laan M, Lötvall J, Lindén A. 2003. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol 170:4665-4672. (Pubitemid 36519973)
11. Motz GT, Eppert BL, Wesselkamper SC, Flury JL, Borchers MT. 2010. Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2-/-mice. Am J Respir Crit Care Med 181:1223-1233.
12. Park SJ, Lee KS, Kim SR, Min KH, Choe YH, Moon H, Chae HJ, Yoo WH, Lee YC. 2009. Peroxisome proliferator-activated receptor gamma agonist down-regulates IL-17 expression in a murine model of allergic airway infammation. J Immunol 183:3259-3267.
13. Shen F, Zhao MW, He B, Pei F, Yao WZ. 2006. Observations on lung function and pathological changes of airway lung tissues in rats with diferent passive-smoking durations. Journal of Guiyang Medical College 31:247-250.
14. Shen F, Zhao MW, He B, Wang YZ, Yao WZ. 2004a. [Te levels and clinical implications of induced sputum interleukin-17 in chronic obstructive pulmonary disease and asthma]. Zhonghua Nei Ke Za Zhi 43:888-890.
15. Shen F, Zhao MW, He B, Yang JJ, Pei F, Wang YZ. 2004b. [Te changes and signifcance of interleukin-17 in rat models of chronic obstructive pulmonary disease and asthma]. Zhonghua Jie He He Hu Xi Za Zhi 27:654-658.
16. Shi Y Ullrich SJ, Zhang J, Connolly K, Grzegorzewski KJ, Barber MC, Wang W, Wathen K, Hodge V, Fisher CL, Olsen H, Ruben SM, Knyazev I, Cho YH, Kao V, Wilkinson KA, Carrell JA, Ebner R. 2000. A novel cytokine receptor-ligand pair. Identifcation, molecular characterization, and in vivo immunomodulatory activity. J Biol Chem 275:19167-19176. (Pubitemid 30422887)
17. Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A. 1999. Airway infammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 14:1015-1022.
18. Takehana Y Hamano S, Kikuchi S, Komatsu H, Okegawa T, Ikeda S. 1990. Inhibitory action of OKY-O46.HCl, a specific TXA2 synthetase inhibitor, on platelet activating factor (PAF)-induced airway hyperresponsiveness of guinea pigs: role of TXA2 in development of PAF-induced nonspecific airway hyperresponsiveness. Jpn J Pharmacol 52:621-630. (Pubitemid 20127320)
19. Wright JL, Churg A. 2002. Animal models of cigarette smoke-induced COPD. Chest 122:301-306.
20. Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduf BM, Spriggs MK, Armitage RJ. 1995. Human IL-17: a novel cytokine derived from T cells. J Immunol 155:5483-5486.